SWTX
SpringWorks Therapeutics Inc
Price:  
38.69 
USD
Volume:  
1,052,028.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SWTX WACC - Weighted Average Cost of Capital

The WACC of SpringWorks Therapeutics Inc (SWTX) is 7.4%.

The Cost of Equity of SpringWorks Therapeutics Inc (SWTX) is 11.10%.
The Cost of Debt of SpringWorks Therapeutics Inc (SWTX) is 5.00%.

Range Selected
Cost of equity 7.90% - 14.30% 11.10%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.8% - 9.0% 7.4%
WACC

SWTX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.87 1.68
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.90% 14.30%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.8% 9.0%
Selected WACC 7.4%